Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood

Thrombosis Research

Volumn 97, Issue 6, 2000, Pages 473-480

  Stief, Thomas W ^a,b   Kurz, J Ürgen ^a   Doss, Manfred O ^a   Fareed, Jawed ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anticoagulant; Antithrombotic; Chloramine; Granulocytes; HOCl; Phagocytes; Singlet oxygen

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; SINGLET OXYGEN; TOSYLCHLORAMIDE SODIUM; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEMOSTASIS; HUMAN; NEUTROPHIL; NORMAL HUMAN; OXIDATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; ASCORBIC ACID; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; CATTLE; FACTOR IX; FACTOR V; FACTOR VII; FACTOR VIII; FACTOR X; FACTOR XII; FACTOR XIII; FIBRINOGEN; HUMANS; METHIONINE; OXIDATION-REDUCTION; OXYGEN; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; PROTHROMBIN; PROTHROMBIN TIME; SINGLET OXYGEN; THROMBIN TIME;

EID: 0034004423     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00211-X     Document Type: Article

References (42)

1. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-376.
2. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome. oxidants, myeloperoxidase, and bacterial killing Blood. 92:1998;3007-3017.
3. Lanir N., Ciano P.S., van de Water L., McDonagh J., Dvorak A.M., Dvorak H.F. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. J Immunol. 140:1988;2340-2349.
4. Inada Y., Hessel B., Blombäck B. Photooxidation of fibrinogen in the presence of methylene blue and its effect on polymerization. Biochim Biophys Acta. 532:1978;161-170.
5. Zeiler T., Riess H., Wittmann G., Hintz G., Zimmermann R., Müller C., Heuft H.G., Huhn D. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion. 34:1994;685-689.
6. Henschen-Edman A.H. Photo-oxidation of histidine as a probe for aminoterminal conformational changes during fibrinogen-fibrin conversion. Cell Mol Life Sci. 53:1997;29-33.
7. Salvemini D., DeNucci R.J., Gryglewski R.J., Vane J.R. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide like factor. Proc Natl Acad Sci USA. 86:1989;6328-6332.
8. Cardinal D.C., Flower R.J. The electronic aggregometer. A novel device for assessing platelet behavior in blood J Pharmacol Methods. 3:1980;135-138.
9. Zatta A., Prosdocimi M., Bertelé V., Bazzoni G., del Maschio A. Inhibition of platelet function by polymorphonuclear leukocytes. J Lab Clin Med. 116:1990;651-660.
10. Williams D.H. Sugaring vancomycin. Nature. 397:1999;567-568.
11. Foote C.S., Clennan E.L. Properties and reactions of singlet oxygen. Foote C.S., Valentine J.S., Greenberg A., Liebman J.F. Active Oxygen in Chemistry. 1995;105-141 Blackie Academic and Professional, London.
12. Stief T.W., Martin E., Jimenez J., Digón J., Rodriguez J.M. Effect of oxidants on proteases of the fibrinolytic system. possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin Thromb Res. 61:1991;191-200.
13. Shechter Y., Burstein A., Patchornik Y. Selective oxidation of methionine residues in proteins. Biochem. 14:1975;4497-4503.
14. Yamazumi K., Shimura K., Terukina S., Takahashi N., Matsuda M. A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi. J Clin Invest. 83:1989;1590-1597.
15. Aly A.M., Higuchi M., Kasper C.K., Kazazian H.H. Jr., Antonarakis S.E., Hoyer L.W. Hemophilia A due to mutations that create new N-glycosylation sites. Proc Natl Acad Sci USA. 89:1992;4933-4937.
16. Gaucher C., Jorieux S., Mercier B., Oufkir D., Mazurier C. The "Normandy" variant of von Willebrand disease. Characterization of a point mutation in the von Willebrand Factor gene Blood. 77:1991;1937-1941.
17. Ribba A.S., Lavergne J.M., Bahnak B.R., Derlon A., Pietu G., Meyer D. Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease. Blood. 78:1991;1738-1743.
18. Gonzalez-Manchon C., Fernandez-Pinel M., Arias-Salgado E.G., Ferrer M., Alvarez M.V., Garcia-Munoz S., Ayuso M.S., Parrilla R. Molecular genetic analysis of a compound heterozygote for the glycoprotein (GP) IIb gene associated with Glanzmann's thrombasthenia. disruption of the 674-687 disulfide bridge in GPIIb prevents surface exposure of GPIIb-IIIa complexes Blood. 93:1999;866-875.
19. 2)/hν). Clin Appl Thrombosis/Hemostasis. in press:2000.
20. Smith O.M., Gaffney D.K., Anderson M.S., McOlash L., Schober S.L. Plasma membrane properties regulating the sensitivity of leukemia, lymphoma, and solid tumor cells to merocyanine 540-sensitized photoirradiation. Exp Hematol. 19:1991;785-788.
21. Martin W., Villani G.M., Jothianandan D., Furchgott R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 232:1985;708-716.
22. Johnstone J.F., Lam L.Y., Lacoste L., Baribeau J., Theroux Waters D. Methylene blue inhibits the antithrombotic effect of nitroglycerin. J Cardiol. 21:1993;255-259.
23. Edwards G.H., Griffith T.M., Ryley H.C., Henderson A.H. Haptoglobin-haemoglobin complex in human plasma inhibits endothelium-derived relaxation. Evidence that endothelium-derived relaxing factor acts as a local autacoid Cardiovasc Res. 20:1986;549-556.
24. Radomsky M.W., Palmer R.M.J., Moncada S. Comparative pharmacology of endothelium- derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 92:1987;181-187.
25. Ignarro L.J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circulation Res. 65:1989;1-21.
26. Jia L., Furchgott R.F. Inhibition by sulfhydryl compounds of vascular relaxing factor. J Pharmacol Exp Ther. 267:1993;371-378.
27. Stuehr D.J., Gross S.S., Sakuma I., Levi R., Nathan C.F. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med. 169:1989;1011-1020.
28. Radomski M.W., Palmer R.M.J., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 87:1990;5193-5197.
29. Stauler J.S., Loscalzo J. The antithrombotic effects of organic nitrates. J Am Coll Cardiol. 18:1991;1529-1536.
30. Shultz P.J., Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 90:1992;1718-1725.
31. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 38:1995;87-104.
32. Stief T.W. Nonradical excited oxygen species induce selective thrombolysis in vivo. Thromb Res. 62:1991;147-163. -.
33. Giri S., Waters D.D., Wu A.H.B. Pathophysiology of acute coronary syndromes. Wu A.H.B. Cardiac Markers. 1998;21-44 Humana Press, Totowa.
34. Deliconstantinos G., Villioutou V., Stavrides J.C. Nitric oxide and peroxynitrite released by ultraviolet B-irradiated human endothelial cells are possibly involved in skin erythema and inflammation. Exp Physiol. 81:1996;1021-1033.
35. Marx R. Hämostaseologie (Habil). München; 1953. p. 350-2.
36. Briviba K., Klotz L.O., Sies H. Toxic and signaling effects of photochemically or chemically generated singlet oxygen in biological systems. Biol Chem. 378:1997;1259-1265.
37. Korytowski W., Bachowski G.J., Girotti A.W. Photoperoxidation of cholesterol in homogeneous solution, isolated membranes, and cells. comparison of the 5 alpha- and 6 beta-hydroperoxides as indicators of singlet oxygen intermediacy Photochem Photobiol. 56:1992;1-8.
38. Wagner J.R., Motchnik P.A., Stocker R., Sies H., Ames B.N. The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen. J Biol Chem. 268:1993;18502-18506.
39. Carr A.C., van den Berg J.J., Winterbourn C.C. Chlorination of cholesterol in cell membranes by hypochlorous acid. Arch Biochem Biophys. 332:1996;63-69.
40. Geiger P.G., Korytowski W., Lin F., Girotti A.W. Lipid peroxidation in photochemically stressed mammalian cells. use of cholesterol hydroperoxides as mechanistic reporters Free Radic Biol Med. 23:1997;57-68.
41. Bhakdi S. Complement and atherogenesis. The unknown connection Ann Med. 30:1998;503-507.
42. de Boer O.J., van der Wal A.C., Teeling P., Becker A.E. Leucocyte recruitment in rupture prone regions of lipid-rich plaques. A prominent role for neovascularization? Cardiovasc Res. 41:1999;443-449.